CSIQ
Canadian Solar Inc
NASDAQ · Semiconductors
$19.89
+0.91 (+4.79%)
CSIQ News2 articles
Novartis Advances with Canadian Reimbursement and Major U.S. R&D Expansion
Novartis shares gained as the company secured a draft reimbursement nod in Canada for Kisqali and broke ground on a $23 billion U.S. research center. Investors eye upcoming dividend and annual meeting.
Merck Shares Approach 52-Week High on Canadian RSV Drug Approval
Merck stock gained 1.8% after Health Canada approved its ENFLONSIA RSV antibody for infants. Guggenheim raised its price target to $140, while insider sales were disclosed.